Podcasts about medreleaf

On this episode of BofC Live, we connect with Darren Karasiuk, CEO of NOVA Cannabis. NOVA Cannabis has launched Value Buds, a cannabis retail chain in Ontario and Alberta focused specifically on long-time cannabis consumers. We wanted to connect with Karasiuk to talk about the approach and strategy of Value Buds, but also talk about Karasiuk’s deep history in the sector, including with MedReleaf and Aurora.Learn more about NOVA Cannabis and Value Buds.

Reefer Reporters January 28th with Kim & CindyThis weeks stories include: Canadian LP's turn to beverages to drive sales, Circle K stores carry cannabis gift cards, Toronto florist selling weed bouquets for valentines day, New study-legalization leads to declining opioid prescriptions, Can cannabis beat big pharma curing Alzheimer's?, Canadian retailer High Tide buys USA headshop, Mexican legalization; now what?, Aurora cannabis partners with Ausi company MedReLeaf, Several nations could legalize in 2021; who's next?, Documentary explores psychedelic drugs for mental healthReefer Reporters airs Monday and Thursday on PACEradio.net

This Week In ... looks at the year in Marijuana Business News, 2018, with hosts Jill Reddish and Kevin "Moose" Huhn: $4B Brave New World: Updates on the launch of California's recreational marijuana market Canada's Landmark Day: Country launches industrialized world's first recreational cannabis market Multibillion-dollar marijuana industry takes the stage at inaugural MJBizConINT'L Ontario to permit cannabis sales at production centers, following Newfoundland's lead Constellation invests CA$5 billion in cannabis giant Canopy in deal financed by BofA Merrill Lynch Cronos lists on Nasdaq, as US gets first 'pure play' marijuana stock on major exchange Canopy Growth becomes first plant-touching cannabis company on NYSE; shares fall Final California marijuana regulations: 'Wins, losses and more ambiguity' Fast pace of Canadian cannabis license approvals fails to avert supply shortage Higher prices and barer shelves: California cannabis retailers face frustrated customers Oklahoma's medical cannabis market set for major growth, with business competition fierce First recreational cannabis stores open in Massachusetts to big crowds Legal medical marijuana sales begin in Pennsylvania Michigan OKs recreational marijuana, creating potential $1.7 billion market Key cannabis legalization wins could bring in upwards of $2 billion in new sales Utah gov signs medical cannabis compromise bill passed by lawmakers NY gov wants to legalize adult-use cannabis in 2019, creating $1.7 billion market New Jersey lawmakers delay action on adult-use marijuana until 2019 AG Sessions rescinds Cole Memo, roiling marijuana industry Trump ousts cannabis threat Jeff Sessions as attorney general Trump taps Justice Department veteran William Barr as attorney general Aurora Cannabis to acquire Canadian rival MedReleaf for CA$3.2B in industry's biggest deal Aurora Cannabis clears final regulatory hurdle in CA$1.2B CanniMed acquisition Aphria buys Nuuvera for CA$826 million, plans to 'dominate' international marijuana market MedMen inks blockbuster $682 million stock deal to acquire medical cannabis firm PharmaCann US cannabis firm iAnthus inks CA$835 million acquisition of MPX Bioceutical Weekly Deal Watch: Brand development, scale drive cannabis dollars Marijuana operator Acreage Holdings announces landmark $119 million funding Cresco Labs closes $100 million raise, draws institutional investors to cannabis industry Privateer sets milestone for US marijuana industry with $100 million raise Oregon recreational cannabis sales soar as prices continue to drop Four takeaways as Big Alcohol makes another foray into Canada’s cannabis market Molson Coors bets on growing cannabis industry with Canadian joint venture  And more! Sponsored by: Citizen Green Community Subscribe to both of our podcasts on iTunes, Stitcher and here on our site!     

Welcome to the Cannabis Show! On today's episode, Kait reports on the top headlines in cannabis news, Basil pays tribute to Matt Mernagh, and the crew answer a question about MedReleaf's new Product Identification Numbers (PINs). All that and more on the Cannabis Show!

Though currently littered with penny stocks, the landscape for investing in marijuana is improving.  Shannon Jones analyzes the recent merger of Aurora Cannabis and MedReleaf, and the impending FDA approval for GW Pharmaceuticals.  Plus, we discuss how professional athletes and owners are helping the case by becoming more vocal about marijuana as a device for pain management. 

#Cannabis Stocks on the Move - Aurora Cannabis (TSX: $ACB.TO) and MedReleaf (TSX: $LEAF.TO) Acquisition

#Cannabis Stocks on the Move - Aurora Cannabis (TSX: $ACB.TO) and MedReleaf (TSX: $LEAF.TO) Acquisition

Aurora Cannabis acquires Medreleaf for 3.2 billion in stock

On this week's episode of the Cannabis Show, Kait explains the benefit of making your own cannabis suppositories, Hart helps us understand the process of decarboxylation, and the crew discuss MedReleaf's Rex Oil. All that and more on the Cannabis Show!

On this week's episode of the Cannabis Show, we take a closer look at MedReleaf's high-CBD strain Trutiva, Hart praises Alberta's plans for recreational cannabis, and a viewer struggles to find sleep relief with indica oil.

This week on the Cannabis Show, using medical cannabis to treat the winter blues, removing terpenes from cannabis oils, and in the latest round of Strain Vs. Strain we see Kait repping Broken Coast's Campania while Basil backs MedReleaf's Orellium.

This week on the Cannabis Show, Chris explores Hollio (aka Blue Dream), a sativa-dominant strain from licensed producer MedReleaf. Hart explains the medicinal properties of the non-psychoactive cannabinoid, CBC (cannabichromene). And a viewer asks how cannabis can be used to alleviate Parkinson's symptoms.

Adam Bierman joins us and lays out his priorities for 2018, those being money, markets and the mainstreaming of the industry. On the money side, he certainly noticed the Constellation Brands deal in Canada (it was of course precluded from happening here in the United States). On markets the Medmen fund investing in Canada in MedReleaf went better than expected. On mainstreaming cannabis. They’ve got 6 retail shops in Southern California which Adam sees as the biggest cannabis market in the world. He’s working with the stores and educating the public on the new reality on the ground as of January 1st. And to that end, on mainstreaming, he’s exposing Medmen and legal cannabis to a whole new market with pride and responsibility.

On this episode of The Cannabis Show, Canadian military veteran Mike Parsons shares his inspiring story in using medical cannabis to treat symptoms related to a hip injury and PTSD, weaning himself off a "cocktail" of pharmaceuticals, and reconnecting with himself, friends and family. "I was on about nine different medications for about 10 years at the time," Parsons recalls. "It was a bumpy road... There was a lot of different types, everything from anti-depressants, mood stabilizers, to things for pain relief." Cannabis, he adds, "brought me back to who I was." Also, Hart and Basil square off in another round of Strain vs. Strain, with Hart trumpeting Hydropothecary's CBD-rich Honeydew strain and Basil champions Medreleaf's high-CBD strain AviDekel.

Chris reviews Rex (aka Tangie) a new strain from Medreleaf, Basil drops knowledge about the 'Mother of All Cannabinoids' CBGA, our growing guru Evan offers tips and options on lighting, Kait explains the bimodal effects of cannabis, and You Canna Ask Us Anything.

On today's show, we finally find what the deal is with Basil's yellow glasses. We also explore MedReleaf's strain Luminarium, learn about the terpene bisabolol, and discuss the importance of the follow-up appointment.